Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huawei Jiang

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Elife|October 21, 2024
Proteogenomic analysis of air-pollution-associated lung cancer reveals prevention and therapeutic opportunitiesHonglei Zhang, Chao Liu, Shuting Wang, et al.
Cancer Immunology Research|October 21, 2024
CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical TrialYang Xu, Xuzhao Zhang, Dijia Xin, et al.
British Journal of Haematology|May 16, 2023
Derivation and validation of a novel score for early prediction of severe CRS after CAR-T therapy in haematological malignancy patients: A multi-centre studyLinghui Zhou, Weijun Fu, Shenghao Wu, et al.
American Journal of Hematology|May 26, 2026
Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA GroupJiajia Pan, Chunmei Fu, Qing Ling, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Elife|October 21, 2024
Proteogenomic analysis of air-pollution-associated lung cancer reveals prevention and therapeutic opportunitiesHonglei Zhang, Chao Liu, Shuting Wang, et al.
Cancer Immunology Research|October 21, 2024
CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical TrialYang Xu, Xuzhao Zhang, Dijia Xin, et al.
British Journal of Haematology|May 16, 2023
Derivation and validation of a novel score for early prediction of severe CRS after CAR-T therapy in haematological malignancy patients: A multi-centre studyLinghui Zhou, Weijun Fu, Shenghao Wu, et al.
American Journal of Hematology|May 26, 2026
Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA GroupJiajia Pan, Chunmei Fu, Qing Ling, et al.
Pageof 7